110 related articles for article (PubMed ID: 1302441)
21. Effect of concomitant colestipol hydrochloride administration on the bioavailability of diltiazem from immediate- and sustained-release formulations.
Turner SW; Jungbluth GL; Knuth DW
Biopharm Drug Dispos; 2002 Dec; 23(9):369-77. PubMed ID: 12469330
[TBL] [Abstract][Full Text] [Related]
22. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
Shah J; Wesnes KA; Kovelesky RA; Henney HR
Clin Ther; 2006 Sep; 28(9):1308-17. PubMed ID: 17062304
[TBL] [Abstract][Full Text] [Related]
23. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
24. Development and pharmacokinetics of a new sustained-release formulation of diltiazem.
Thiercelin JF; Necciari J; Caplain H; Cournot A; Combes M; Desmolin H; Flouvat B
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S31-7. PubMed ID: 1706011
[TBL] [Abstract][Full Text] [Related]
25. Influence of grape juice and orange juice on the pharmacokinetics and pharmacodynamics of diltiazem in healthy human male subjects.
Ahmed T; Sajid M; Singh T; Saini GS; Monif T; Saha N; Pillai KK
Int J Clin Pharmacol Ther; 2008 Oct; 46(10):511-8. PubMed ID: 18826865
[TBL] [Abstract][Full Text] [Related]
26. Comparative effects of diltiazem sustained-release and captopril on blood pressure control and plasma lipoproteins in primary hypertension: a randomized, double-blind, crossover study.
Lacourcière Y; Poirier L; Boucher S; Spenard J
J Hum Hypertens; 1990 Oct; 4(5):553-6. PubMed ID: 2283645
[TBL] [Abstract][Full Text] [Related]
27. Effects of sustained-release diltiazem on blood pressure and serum lipids: a multicenter, randomized, placebo-controlled study.
Djian J; Fermé I; Zannad F; Chaignon M; Asmar R
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S38-45. PubMed ID: 1706012
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic model of diltiazem.
Kölle EU; Ochs HR; Vollmer KO
Arzneimittelforschung; 1983; 33(7):972-7. PubMed ID: 6684932
[TBL] [Abstract][Full Text] [Related]
29. Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervals.
Sundberg S; Antila S; Scheinin H; Häyhä M; Virtanen M; Lehtonen L
Int J Clin Pharmacol Ther; 1998 Dec; 36(12):629-35. PubMed ID: 9876999
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the daily variation in blood pressure and pharmacokinetics after single or repeated administration of clentiazem to patients with essential hypertension.
Suzuki S; Mori M; Kusano S
Arzneimittelforschung; 1992 Apr; 42(4):533-9. PubMed ID: 1642678
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of a novel diltiazem HCl extended-release tablet formulation for evening administration.
Sista S; Lai JC; Eradiri O; Albert KS
J Clin Pharmacol; 2003 Oct; 43(10):1149-57. PubMed ID: 14517197
[TBL] [Abstract][Full Text] [Related]
32. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
[TBL] [Abstract][Full Text] [Related]
33. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
34. Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers.
Deroubaix X; Lins RL; Lens S; Demblon C; Jeanbaptiste B; Poelaert D; Stockis A
Int J Clin Pharmacol Ther; 1996 Feb; 34(2):61-70. PubMed ID: 8929748
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
[TBL] [Abstract][Full Text] [Related]
36. The effect of nifedipine on the pharmacokinetics and dynamics of diltiazem: the preliminary study in normal volunteers.
Tateishi T; Ohashi K; Sudo T; Sakamoto K; Fujimura A; Ebihara A
J Clin Pharmacol; 1993 Aug; 33(8):738-40. PubMed ID: 8408735
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and pharmacodynamics of a slow-release formulation of diltiazem after the administration of a single and repeated doses to healthy volunteers.
Lefebvre M; Lacasse Y; Spénard J; Geadah D; Moisan R; Gossard D; Landriault H; Du Souich P; Caillé G
Biopharm Drug Dispos; 1994 Apr; 15(3):227-42. PubMed ID: 7880983
[TBL] [Abstract][Full Text] [Related]
38. Conventional and controlled release diltiazem. Bioavailability in healthy volunteers and anti-anginal effects in combination with metoprolol in stable angina pectoris.
Brorson L; Arvill A; Löfdahl P; Jörgensen E; Fraser T; Larsson H; Olsson AM; Olsson SO
Eur J Clin Pharmacol; 1994; 47(1):75-9. PubMed ID: 7988629
[TBL] [Abstract][Full Text] [Related]
39. In vitro/in vivo correlation of prolonged release dosage forms containing diltiazem HCI.
Caramella C; Ferrari F; Bonferoni MC; Sangalli ME; De Bernardi di Valserra M; Feletti F; Galmozzi MR
Biopharm Drug Dispos; 1993 Mar; 14(2):143-60. PubMed ID: 8453024
[TBL] [Abstract][Full Text] [Related]
40. Comparisons of the effects of different long-acting delivery systems on the pharmacokinetics and pharmacodynamics of diltiazem.
Smith DH; Neutel JM; Weber MA
Am J Hypertens; 1999 Oct; 12(10 Pt 1):1030-7. PubMed ID: 10560790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
